Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ReNeuroGen Logo
ReNeuroGen Growth Score
40
CB Rank
203482
Heat Score
39
ReNeuroGen is a virtual pharmaceutical company.
Founded
obfuscation
PrivateGrant Elm Grove, Wisconsin, United States1-10 www.rngen.com/
Health Care
Pharmaceutical
Overview

ReNeuroGen
Total Funding
obfuscation
Growth Score
40
Heat Score
39

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score40
-1 pts
in past quarter
Heat Score 39
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ReNeuroGen

CB Rank
203482
ReNeuroGen is a virtual pharmaceutical company.
Founded
obfuscation
PrivateGrant Elm Grove, Wisconsin, United States1-10 www.rngen.com/
Health Care
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Non-equity Assistance
OBF
in
obfuscation

Key People

  • Stephen Naylor Logo
    Stephen Naylor: Co-Founder, CEO and Board Chairman.
    Past Role: iMetabolic Biopharma Corporation, Chairman and COO
  • Photo of Kirkwood A. Pritchard
    Kirkwood A. Pritchard: Chief Scientific Officer
    Past Role: New York Medical College, Associate Professor

Details

Operating Status Active
Company Type For Profit
Founders  Kirkwood A. Pritchard, Stephen Naylor
About the Company
ReNeuroGen is a virtual pharmaceutical company developing systems pharmacology therapies with a focus on neurological and pulmonary disease indications.
Phone Number 1-412-972-0134
Contact Email info@rngen.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

KYC (N-acetyl-lysyltyrosylcysteine amide)
A tripeptide myeloperoxidase inhibitor developed to reduce inflammation and oxidative damage in diseases affecting neurological and pulmonary systems.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant
obfuscation
Grant - ReNeuroGen Logo
Grant - ReNeuroGen
1
obfuscation
SBIR AdvanceGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 3

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

47

IT Spend

$49.2KThis year, ReNeuroGen is projected to spend $49.2K on IT, according to Aberdeen.

Active Website Tech Count

2ReNeuroGen is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.

Total IP

1ReNeuroGen has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ReNeuroGen's headquarters? ReNeuroGen is located in Elm Grove, Wisconsin, United States.Who invested in ReNeuroGen? ReNeuroGen has 2 investors including SBIR Advance and  gbeta.When was the last funding round for ReNeuroGen? ReNeuroGen closed its last funding round on
obfuscation
from a Grant round.Who are ReNeuroGen's competitors? Alternatives and possible competitors to ReNeuroGen may include Capricor Therapeutics, Axsome Therapeutics, and  Aclaris Therapeutics.How much funding has ReNeuroGen raised to date? ReNeuroGen has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|